🧬 Pharma's Coordination Tax & the 2 Paths That Could Actually Disrupt It | Alex Telford (3/4)
In this episode, Jon Chee sits down with Alex Telford, founder of Convoke, to examine why large pharma resists AI transformation. Drawing on seven years at Charles River Associates, Alex maps the coordination tax of siloed orgs, the tacit knowledge lost when experts retire, and why software efficiency is the wrong axis to compete on. His frame: factory electrification — the gains don't arrive until you redesign the whole org around the technology.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Biotech Startups Podcast
🧬 The Rule of Three: Career, Family & One Other Thing | Mati Gill (1/4)
🧬 From Reactive Data to Predictive Intelligence: Inside Convoke's Platform | Alex Telford (4/4)
🧬 AI Psychosis, Coordination Tax & the Limits of LLMs | Alex Telford (2/4)
🧬 From Expat Kid to Founder: Science, Curiosity & the Long Road to Conviction | Alex Telford (1/4)
Get summaries like this every morning.
Free AI-powered recaps of The Biotech Startups Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.